Hydroxyurea
Hydroxyurea is an antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. Hydroxyurea activates apoptosis and autophagy. Hydroxyurea is used to treat HIV infection.
| Trivial name | NCI-C04831, Hydroxycarbamide,NSC-32065 |
| Catalog Number | S1896 |
| Molecular Formula | C15H29N3O5 |
| CAS# | 127-07-1 |
| Inchi | InChI=1S/C15H29N3O5/c1-8(2)7-9(10(19)13(21)18-23)12(20)17-11(14(22)16-6)15(3,4)5/h8-11,19,23H,7H2,1-6H3,(H,16,22)(H,17,20)(H,18,21)/t9-,10+,11-/m1/s1 |
| Inchi Key | OCSMOTCMPXTDND-OUAUKWLOSA-N |
| SMILES | CC(C)CC(C(C(=O)NO)O)C(=O)NC(C(=O)NC)C(C)(C)C |
| Size | 10mM/1mL |
| Supplier Page | http://www.selleckchem.com/products/Hydroxyurea(Cytodrox).html |
| Additional Information | https://file.selleck.cn/downloads/struct/Hydroxyurea-Cytodrox-chemical-structure-S1896.gif |